Skip to content
Minapharm
-
Minapharm secures US$16.5M CEPI funding for Bundibugyo Ebola vaccine
Minapharm’s candidate is the fifth Bundibugyo-specific vaccine supported by CEPI as the Democratic Republic of the Congo (DRC) responds to a rapidly escalating outbreak.